NCT05637632View on ClinicalTrials.gov

Assessment of Recombinant HAT-RDT Specificity

CompletedOBSERVATIONAL

Enrollment

1,504

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions

Human African Trypanosomiasis

Trial Locations (1)

0000

Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Kinshasa

All Listed Sponsors

lead

Institute of Tropical Medicine, Belgium

OTHER